Discovery on Demand, Accelerating Drug Discovery

Nanosyn, provider of Discovery on Demand  services, is a medicinal chemistry and biological services contract research organization providing made-to-order focused compound libraries, hit-to-lead optimization, medicinal chemistry services and other innovative solutions to meet your drug discovery needs.

Our proprietary technology allows us to provide superior chemistry and biology services that effectively accelerate the drug discovery process for biotechnology and pharmaceutical companies worldwide.

Quick Links 

List of Available Assays: Click here

Plug & Play Libraries: Click here    

Contact Page: Click here   


Latest News

October 21, 2014 - Nanosyn and The Leukemia & Lymphoma Society (LLS) extend their research collaboration. Click here for more information.
July 21, 2014 - Nanosyn announced today a multi-year research services agreement with FORMA Therapeutics, Inc., to provide access to Nanosyn's microfluidics screening and profiling capabilities and proprietary fragment-based lead discovery platform for novel small molecule therapeutics. Click here for more information.
September 24, 2012 - Nanosyn announced today that it has launched a new service based on its proprietary Fragment Based Lead Discovery platform.  The service includes identification of fragments with high ligand efficiency; lead generation; lead optimization and further development all the way through manufacturing of commercial APIs. Utilization of the platform allows Nanosyn to offer an integrated and cost effective solution of delivering optimized leads and clinical candidates to its clients. Please contact us for more information.